PBM Reform Act of 2025
Sponsor

Full profile: /officials/C001103
Source: Congress.gov · FEC
Cosponsors (70)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Debbie Dingell (D-MI-6)Original· 2025-07-10
- Deborah K. Ross (D-NC-2)Original· 2025-07-10
- Derek Tran (D-CA-45)Original· 2025-07-10
- Diana Harshbarger (R-TN-1)Original· 2025-07-10
- Gregory F. Murphy (R-NC-3)Original· 2025-07-10
- Jodey C. Arrington (R-TX-19)Original· 2025-07-10
- John W. Rose (R-TN-6)Original· 2025-07-10
- Nicole Malliotakis (R-NY-11)Original· 2025-07-10
- Raja Krishnamoorthi (D-IL-8)Original· 2025-07-10
- Rick W. Allen (R-GA-12)Original· 2025-07-10
- Vicente Gonzalez (D-TX-34)Original· 2025-07-10
- Ro Khanna (D-CA-17)· 2025-07-14
- Greg Landsman (D-OH-1)· 2025-07-15
- Charles J. "Chuck" Fleischmann (R-TN-3)· 2025-07-16
- J. Luis Correa (D-CA-46)· 2025-07-16
- Jake Auchincloss (D-MA-4)· 2025-07-21
- Sanford D. Bishop, Jr. (D-GA-2)· 2025-07-21
- Andy Harris (R-MD-1)· 2025-07-25
- Ralph Norman (R-SC-5)· 2025-07-25
- Suhas Subramanyam (D-VA-10)· 2025-07-25
- Richard McCormick (R-GA-7)· 2025-07-29
- Randy K. Weber, Sr. (R-TX-14)· 2025-08-12
- Mariannette Miller-Meeks (R-IA-1)· 2025-08-15
- Jill N. Tokuda (D-HI-2)· 2025-08-26
- Marie Gluesenkamp Perez (D-WA-3)· 2025-09-02
- Nikki Budzinski (D-IL-13)· 2025-09-02
- Mike Flood (R-NE-1)· 2025-09-03
- Robert P. Bresnahan, Jr. (R-PA-8)· 2025-09-08
- Tim Moore (R-NC-14)· 2025-09-08
- Tracey Mann (R-KS-1)· 2025-09-08
- James Comer (R-KY-1)· 2025-09-09
- Sarah McBride (D-DE)· 2025-09-18
- Nicholas A. Langworthy (R-NY-23)· 2025-09-30
- Scott Franklin (R-FL-18)· 2025-09-30
- Craig A. Goldman (R-TX-12)· 2025-10-03
- Julie Johnson (D-TX-32)· 2025-10-03
- Kat Cammack (R-FL-3)· 2025-10-08
- Rashida Tlaib (D-MI-12)· 2025-10-10
- Angie Craig (D-MN-2)· 2025-10-17
- Ken Calvert (R-CA-41)· 2025-10-21
- Michael Cloud (R-TX-27)· 2025-10-21
- Josh Harder (D-CA-9)· 2025-10-24
- Kweisi Mfume (D-MD-7)· 2025-10-28
- Burgess Owens (R-UT-4)· 2025-10-31
- Jennifer A. Kiggans (R-VA-2)· 2025-10-31
- Chrissy Houlahan (D-PA-6)· 2025-11-04
- Scott H. Peters (D-CA-50)· 2025-11-07
- Hillary J. Scholten (D-MI-3)· 2025-11-12
- Mark B. Messmer (R-IN-8)· 2025-11-12
- Pete Sessions (R-TX-17)· 2025-11-12
- Maggie Goodlander (D-NH-2)· 2025-11-17
- Terri A. Sewell (D-AL-7)· 2025-11-17
- Tom Barrett (R-MI-7)· 2025-11-20
- Sheri Biggs (R-SC-3)· 2025-11-21
- Yvette D. Clarke (D-NY-9)· 2025-11-28
- Sharice Davids (D-KS-3)· 2025-12-01
- Harold Rogers (R-KY-5)· 2025-12-03
- Cliff Bentz (R-OR-2)· 2025-12-09
- Gabe Vasquez (D-NM-2)· 2025-12-09
- Joe Wilson (R-SC-2)· 2025-12-09
- Ryan Mackenzie (R-PA-7)· 2025-12-09
- Brian Babin (R-TX-36)· 2025-12-16
- Donald G. Davis (D-NC-1)· 2025-12-16
- John Joyce (R-PA-13)· 2025-12-16
- Neal P. Dunn (R-FL-2)· 2025-12-19
- Jefferson Van Drew (D-NJ-2)· 2026-01-08
- Michael Lawler (R-NY-17)· 2026-01-12
- Johnny Olszewski, Jr. (D-MD-2)· 2026-01-20
- Derrick Van Orden (R-WI-3)· 2026-01-21
- Robert Menendez (D-NJ-8)· 2026-04-16
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-07-10
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Ways and MeansReferred To · 2025-07-10
- House Committee on Education and WorkforceReferred To · 2025-07-10
- House Committee on Energy and CommerceReferred To · 2025-07-10
Previously
- Ways and Means CommitteeReferred To · 2025-07-10
- Education and Workforce CommitteeReferred To · 2025-07-10
- Energy and Commerce CommitteeReferred To · 2025-07-10
Plain-English Summary
Pharmacy benefit managers (PBMs) are companies that handle prescription drug coverage for insurance plans, and this bill would impose new regulations on how they operate—likely including requirements around pricing, formulary decisions, and transparency. The changes would affect patients paying for medications, insurance companies, pharmacies, and the PBMs themselves. The bill has been sent to multiple House committees to review different aspects of the proposal.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR2821FDA Modernization Act 3.0Reported by Committee · 2026-05-21
- HR8678Zero Tolerance for Political Violence Act of 2026Referred to Committee · 2026-05-07
- HR8538Save America’s Family Forests Act of 2026Referred to Committee · 2026-04-28
- HR2493Improving Care in Rural America Reauthorization Act of 2025Passed House · 2026-04-22